Transcranial Magnetic Stimulators Market is boosted with rising prevalence of neurological disorders

Transcranial magnetic stimulation (TMS) is a non-invasive method of brain stimulation which uses magnetic induction forces focusing on a particular area of the brain. The electromagnetic induction is generated from a coil using electricity and these pulses travel through the cranium to its specified receptor area of the brain. Several different methods of brain stimulation are available including electroconvulsive therapy and deep brain stimulation techniques; however, currently, the transcranial magnetic stimulation technique is the most widely adopted method for brain stimulation. Transcranial magnetic stimulator devices consist of a coil and a system for analyzing and detection of the effects of the therapy. The coils used in TMS equipment are of different materials such as a coil made up of magnetically inert material (air-core design) or a magnetically active material (solid-core design), depending upon the variations and biophysical characteristics required.

Single or paired pulse TMS and repetitive TMS (rTMS) are the two types of transcranial magnetic stimulation techniques. The single or paired pulse TMS is currently the most widely adopted technique; however, promising results of the rTMS technique for treatment of various psychiatry disorders and rising clinical studies proving the efficiency of the technique are expected to drive the rTMS stimulators segment in the next few years. Applications of transcranial magnetic stimulators include research, diagnostics, and therapeutics. Diagnostic applications include evaluation of the effects of diseases such as stroke, multiple sclerosis, and other neurological diseases on the brain. Therapeutic applications of transcranial magnetic stimulators include treatment of treatment-resistant major depression, migraine, obsessive compulsive disorder (OCD), schizophrenia, and post-traumatic stress, among other psychiatry diseases. Various clinical trials are under way for the application of transcranial magnetic stimulation technique in the treatment and diagnosis of other major diseases affecting the brain.

Major factors expected to drive the transcranial magnetic stimulators market during the forecast period are rising prevalence of neurological disorders including schizophrenia and other disorders, surging geriatric population leading to increasing brain disorders associated with age, growing applications of the transcranial magnetic stimulation technique in diagnosis and treatment of neurological disorders, favorable reimbursements, and new and technologically advanced products introduced by manufacturers such as neuro-navigating stimulators in the global market. However, clinically proven high efficiency of electroconvulsive therapy in the treatment of psychotic depression and rising number of patients adopting the therapy is likely to be one of the major restraints of the transcranial magnetic stimulators market during the forecast period.

In terms of region, the global transcranial magnetic stimulators market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global transcranial magnetic stimulators market from 2017 to 2025, owing to factors such as a large patient population suffering from depression and other psychological and neurological disorders, growing number of devices receiving regulatory approvals, rising demand for new and advanced stimulators, and favorable reimbursement policies. According to Centers of Disease Control and Prevention (CDC) statistics, an estimated 3.5 million to 4 million people in the U.S. alone were suffering from treatment-resistant depression. There has been increasing collaborations and partnerships in the global market between companies and research universities for the advancement of the devices and technology along with widening the scope of applications of the transcranial magnetic stimulators. This along with increasing approvals present wide opportunities for the market players operating in the region. However, rising incidence of psychological disorders in Asia Pacific, increasing health care expenditure, and rising demand for new techniques for the treatment of these disorders are expected to augment the transcranial magnetic stimulators market in Asia Pacific from 2017 to 2025.

Key players operating in the global transcranial magnetic stimulators market include Axilum Robotics, Mastigm, Nexstim plc, Neuronetics, Inc., Brainsway Ltd., and TMS Neuro Solutions.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Source:
http://www.editiontruth.com/transcranial-magnetic-stimulators-market/

TMS: An Alternative to Treating Depression with Medication

Depression affects millions of people every year, turning everyday tasks and issues into overwhelming monsters that take hold of people. It can be the result of surgeries, money problems, relationship struggles, and other traumatic events, but there are ways you can fight back.

Through medication and psychotherapy, or talking therapy, most diagnosed depression cases can be controlled. Sometimes, these aids aren’t enough and sometimes people have other reason for not wanting to take medications, so alternative methods of controlling depression had to be developed.

The is where Transcranial Magnetic Stimulation (TMS) comes in. This alternative form of depression control has been helping those people who can’t take medication, or who find medication doesn’t work for them, find relief from the symptoms of depression.

What is TMS?

TMS therapy is a brain stimulation method that uses focused magnetic pulses to help depressed brainwaves react as they should. While treating depression with TMS, the goal is the stimulation of the nerve cells in the area of the brain the is believed to control mood.

This non-invasive technique is FDA approved for treating the symptoms of depression if they have no reacted to prior antidepressant treatment, and those who have difficulty with the side effects of medication based treatments.

How Does It Work?

The process takes a few set up meetings before your treatments can begin. This a delicate process involving your brain, so careful measurements are taken to locate the left dorsolateral prefrontal cortex.

Additional measurements are taken to determine the proper magnetic strength to use for each patient. When the brain is stimulated by magnetic pulse, the thumb on the opposite side of the stimulant will twitch. This is the strength used in your treatments.

Your psychiatrist uses a large MRI style magnet to send magnetic pulses to your left dorsolateral cortex. Like an electric generator, the magnet can manipulate and produce electrical currents in the brain. Since patients with depression have decreased activity in the left dorsolateral prefrontal cortex, the ultimate goal is to restore activity to those regions.

Treatments last anywhere from 15 minutes to a half-hour, and they normally are done 5 days a week for 4-6 weeks.

Is it Safe?

Yes. The numbers don’t lie, and the FDA gave it the green light for use in fighting depression. The process is non-systemic, meaning it doesn’t float around in your bloodstream like normal anti depression medications. It’s also non-invasive meaning no cuts and scars to deal with either.

Less than 6% of patients stopped their treatment due to a bad experience, and most report that TMS feels like an electronic woodpecker that just pokes your head.

There have been more than 10,000 clinical trials to test the validity and safety of TMS as an alternative depression treatment method.

There also isn’t a list of adverse side affects you can see with normal depression medications either. There are no specific side effects, sexual dysfunction, weight gain, nausea, sedation, dry mouth, no effects on concentration or memory, and no drug interactions either.

You can drive yourself to and from your appointments too!

Who is it for?

Let’s start with who shouldn’t use it:

• Patients with metallic devices in their head
• Patients with implants controlled by physiological signals
• Patients with pacemakers
• Patients with implanted cardioverter defibrillators (ICDs)
• Patients with vagus nerve stimulators (VNS)

So, who does benefit from it? These are the people that can benefit from TMS:

• Patients who have not responded to psychotherapy
• Patients who have not responded to medications
• Patients who have difficulty with the side effects of antidepressants medications
• Patients who don’t want to take their medication for pregnancy or breastfeeding
• Patients who don’t want to take part in ECT

Conclusion

Transcranial Magnetic Stimulation has been a superstar when it comes to finding effective alternatives to treating depression. The use of magnetic pulses to jumpstart brain activity is a promising and safe alternative to the medication methods. Especially as time goes by, we continue to see higher response rates to TMS treatments when anti depression medication has not worked.

If you have been trying to control your depression with medication but you haven’t found any luck in doing so, it might be time to talk to your psychiatrist about alternative depression treatment methods to see if TMS is an option.

Have you or a loved one been helped by TMS? How has TMS helped you when anti depression medications couldn’t? Share your stories about transcranial magnetic stimulation in the comments below.

Drug-free depression treatment gets boost from health insurer

The treatment of depression has been given a boost with a major health insurer funding a non-drug approach to improve symptoms.

Transcranial Magnetic Stimulation (TMS) involves the use of a magnetic coil to stimulate nerve cells in the brain.

The non-invasive treatment takes up to 40 minutes and patients need multiple sessions over several weeks.

Professor Colleen Loo said robust evidence showed TMS helped about 50 percent of patients.

"That's often despite having failed treatment with antidepressant medications and psychological therapy," UNSW Prof. Loo, a psychiatrist based at Sydney's Black Dog Institute, told 9NEWS.

Medibank said it will cover the cost of up to 20 sessions for its members as part of a pilot program across the country.

"We're really excited about this pilot, it's a real breakthrough, it's a first in Australia for a private health insurer to fund outpatient TMS," Dr Andrew Wilson, Medibank's Group Executive of Healthcare & Strategy, said.

The program will help patients avoid having to be admitted to hospital to access treatment.

Prof. Loo said TMS was not Medicare funded and the cost of treatment was an issue among patients who are eligible.

"It's really sad when they then say to us, well I just can't afford it, because you're probably looking at $3000 to $4000 for a treatment course of TMS," she said.

The Medibank program will be trialled for a year so it can be evaluated for customer take up.

Dr Loo said it's a step in the right direction but wider access was needed, given TMS had been established for several years as an effective treatment.

"Because it's not funded by Medicare, this is a problem," she said.

More than one million Australians suffer from depression and psychiatry is in the top five most common hospital claims among Medibank customers.

Psychiatry is the most common hospital claim for members aged in their 20s.

"Mental health does impact on young people disproportionately so it's very important from a mental health perspective that young people get the most effective treatment as quickly as possible," Dr Wilson said.

"For many people TMS can be a life saving treatment for depression."

Source:
https://www.9news.com.au/national/2018/01/05/20/39/alternative-drug-free-depression-treatment-delivers-results

LFMS Treatment: How to Use LFMS Therapy to Treat Insomnia and Depression?

A few Treatments for Brain Stimulation:

Brain incitement medicines like electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS) are frequently successful for the treatment of depression. For instance, a patient may get a few weeks of regular ECT treatments before a full response achieved. Consequently, there is a force to create stimulant medicines that acts quickly to improve the state of mind. It uses magnetic fields that are having a small amount of the strength but have higher frequency than the electromagnetic fields utilized in TMS and ECT. For sure, the potential stimulant properties of LFMS were found accidently, while specialists were directing an imaging study in healthy volunteers.

Utilization of Magnets in Magnetic Therapy:

One of the ways magnets and magnetic fields help the body is by expanding blood flow. That is really good news from people who experience the ill effects from insomnia since more blood in your cerebrum implies more relaxation and a better possibility of falling asleep and sleeping through the night. People have been utilizing magnets for treatment for 100s of years now; however the magnetic therapy for insomnia was out of range for some people. That is a result of the high cost of magnetic field products designed for enhanced sleep. Presently, with the recent advent of inexpensive blankets, mattress and bedding covers with small magnets sewn within them, thousands of people are getting help.

Comparing the Treatments by Experimenting on Patients:

At that point it is planned and constructed as a portable LFMS gadget that conveys a low-quality, high-frequency, electromagnetic field waveform to the cerebrum. An aggregate of 63 currently depressed patients, diagnosed to have either main depressive disorder or bipolar disorder. Those patients are participated in the study and were randomized to get a single 20-minute of genuine LFMS Treatment or sham LFMS, where the device was on however the electromagnetic fields were idle. Since neither the patients nor the analysts realized what treatment each person really got, the genuine impact of the LFMS could be measured.

Results of Comparison:

An immediate and significant improvement was seen in the patients who got genuine LFMS, compared with the individuals who got the sham treatment. There were no reported side effects. This finding recommends that LFMS may have the ability to provide instant relief of depressed state of mind, maybe even in emergency situations. It also confirms the achievement of the device’s design.